Cost-Effectiveness Studies of PET in Oncology

摘要: The ever-increasing need to rigorously demonstrate the cost-effectiveness of PET and other new diagnostic imaging modalities has emerged in current context evidence-based medicine. Governments purchasers health care have a responsibility ensure that there is good evidence procedures purchased on behalf patients are both safe effective. For example, since 1998, Australian government adopted mechanisms existing medical attracting benefits supported by scientific cost effectiveness [11]. inevitable constraints fixed budgets for results compare value money obtained one procedure comparison another. Hence beneficial effects produced particular intervention be balanced against producing this effect, process known as or cost-benefit analysis. This chapter reviews available methods assessing studies various clinical applications imaging. difficulties translating from country another will also addressed.